Why Did DELL, ROIV, SHEL Stocks Surge To 52-Week Highs Today?
Investors rewarded three very different catalysts spanning artificial intelligence, biotechnology, and energy.
Stocktwits
Why Did DELL, ROIV, SHEL Stocks Surge To 52-Week Highs Today?
Investors rewarded three very different catalysts spanning artificial intelligence, biotechnology, and energy.
Stocktwits
More News
Stocks Making Noise as the Market Hunts for Its Next Big Winners
The small-cap market is serving up a mix of stories centered on PDS Biotech (NASDAQ:PDSB), NeOnc (NASDAQ:NTHI), CEA Industries (NASDAQ:BNC), Bluejay Diagnostics (NASDAQ:BJDX), NuRAN Wireless (NASDAQ:NUR) and Roivant Sciences (NASDAQ:ROIV).
24-7 Market News
These 2 Biotech Stocks Hit Record Highs Today – What’s Driving The Rallies?
Roivant Sciences reported positive Phase 2 results for its experimental lung disease drug, Mosliciguat, while Pharvaris’ oral therapy met the main goal of a Phase 3 study of preventive treatment for hereditary angioedema.
Stocktwits
Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday
U.S. stocks fell Tuesday, but Roivant surged 16% on positive PH-ILD trial data. Pharvaris, Solaris, IonQ and quantum stocks also posted strong gains.read more...
Benzinga
Roivant’s Experimental Lung Disease Drug Hits Key Phase 2 Goal – ROIV Stock Tracks All-Time High
Roivant’s Mosliciguat reduced pulmonary vascular resistance by 56.3% compared with placebo after 16 weeks.
Stocktwits
ABUS Stock Surges 10% Today — What’s Driving This Super Rally?
Arbutus Biopharma said it will repurchase $230 million of its common shares at a purchase price of not less than $5 per share and not more than $5.75 apiece, in cash.
Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of 0.00% and -35.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Fortrea Holdings Inc. (FTRE) Surpasses Q2 Earnings and Revenue Estimates
Fortrea Holdings Inc. (FTRE) delivered earnings and revenue surprises of +27.78% and +4.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week
Arbutus expects to receive around $179 million from Moderna.
Stocktwits
Could Roivant Sciences Be a Multibagger Stock Over the Next 5 Years?
Key PointsRoivant Sciences anticipates three commercial launches over the next few years, led by brepocitinib...